Avantor, Inc. reported $6.56B of revenue over the trailing twelve months, −1.6% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $6.56B (to Q2 2026). Net income: −$578M, trailing twelve months to Q2 2026. Free cash flow: $455M, trailing twelve months to Q2 2026. Operating margin: −4.7%, trailing twelve months to Q2 2026.

AVTRAvantor, Inc.

Healthcare

$17.29+19% 1Y

$17.29

$7.4152 weeks$17.29

Latest close: a new 52-week highOct 23, 2026what changed →

AVTR as reported

Avantor, Inc. reported $6.56B of revenue over the trailing twelve months, −1.6% on the year before. 11 reported series are charted on this page, each one as filed.

$6.56B

Revenue, trailing twelve months · to Q2 2026 · −1.6% against the twelve months before

Net income: −$578M
Net income · −184% year on year · trailing twelve months to Q2 2026
Free cash flow: $455M
Free cash flow · −18% year on year · trailing twelve months to Q2 2026
Operating margin: −4.7%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for AVTR, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$6.56B	−1.6%	Q2 2026
Net income	−$578M	−184%	Q2 2026
EPS	−$0.84	−185%	Q2 2026
Gross margin	32%	n/a	Q2 2026
Operating margin	−4.7%	n/a	Q2 2026
Net margin	−8.9%	n/a	Q2 2026
ROE	−7.8%	n/a	Q2 2026
ROA	−3.7%	n/a	Q2 2026
ROIC	−1.3%	n/a	Q2 2026
Free cash flow	$455M	−18%	Q2 2026
P/E	26.7	n/a	Q2 2025 · 4 quarters behind

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.